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ABSTRACT 1 
Cell fate determination is influenced by interactions between master transcription factors (TFs) 2 
and cis-regulatory elements. Hepatocyte nuclear factor 4 alpha (HNF4A), a liver-enriched TF, 3 
acts as a master controller in the specification of hepatic progenitor cells by regulating a network 4 
of TFs that controls the onset of hepatocyte cell fate. Using analysis of genome-wide histone 5 
modifications, DNA methylation and hydroxymethylation in mouse hepatocytes, we show that 6 
HNF4A occupies active enhancers in hepatocytes and essential for active histone (H3K27ac) 7 
and DNA signatures, especially 5-hydroxymethylcytosine (5hmC). In mice lacking HNF4A 8 
protein in hepatocytes, we observed a decrease in both H3K27ac and hydroxymethylation at 9 
regions bound by HNF4A. Mechanistically, HNF4A-associated hydroxymethylation (5hmC) 10 
requires its interaction with TET3, a protein responsible for the oxidation from 5mC to 5hmC. 11 
Furthermore, HNF4A regulates TET3 expression in liver by directly binding to an enhancer 12 
region. In conclusion, we identified that HNF4A is required for the active epigenetic state at 13 
enhancers that facilitates transcription from genes in hepatocytes. 14 
 15 
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INTRODUCTION: 25 
Hepatocyte nuclear factor 4A (HNF4A, also known as NR2A1) is a member of the 26 
nuclear receptor superfamily of transcription factors (TFs) and is expressed in the liver, 27 
pancreas, gastrointestinal tract and kidneys (1). In the liver, HNF4A is required for normal liver 28 
development (2), including morphogenesis (3) and differentiation (4), and controls a set of genes 29 
necessary for hepatocyte functions. HNF4A deficiency in the mouse embryonic liver causes 30 
failure in hepatocyte differentiation (2), while in adult mice loss of HNF4A affects lipid 31 
homeostasis resulting in liver steatosis (5). In humans, HNF4A mutations have been linked to 32 
maturity-onset diabetes of young type1 (MODY-1), a monogenic form of type 2 diabetes (6). In 33 
addition to maintaining the expression of various genes associated with metabolic processes in 34 
the liver, several studies have connected reduced HNF4A expression with liver cancer 35 
progression (7). HNF4A disruption in mature hepatocytes has been shown to result epithelial to 36 
mesenchymal transition (EMT), a process associated with cancer progression (8). Conversely, its 37 
overexpression in hepatocellular carcinoma rodent models shows its role in tumour suppression 38 
(4, 7) by repressing the proliferative capacity of cancer cells(9). Taken together, these studies 39 
strongly support a role for HNF4A as a central regulator of hepatocyte identity by playing a 40 
crucial function in regulating liver gene expression (5, 10). However, the mechanisms through 41 
which HNF4A exerts its functions are not well understood. 42 
TFs, such as HNF4A, primarily function through directly binding to DNA at sequence-43 
specific motifs; however, the number of potential binding sites for a given TF across the genome 44 
far exceeds the binding events observed in vivo. We have shown that HNF4A binding is highly 45 
dynamic and that binding events can change based on tissue and the differentiation state (11). 46 
Genome-wide analysis of mammalian genomes has provided evidence that active cis-regulatory 47 
regions are located in open chromatin regions (12), while condensed chromatin is inaccessible 48 
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and thus inactive. How chromatin structure is regulated in tissue- and differentiation stage-49 
specific patterns and how TFs play a role in the adaptation of the chromatin structure is only 50 
beginning to be explored. 51 
DNA methylation and histone modifications are two of the primary mechanisms of 52 
epigenetic control that influence chromatin condensation and DNA accessibility. Histone 53 
modifications that include methylation and acetylation of histone tails have been associated with 54 
repressed, poised and active enhancers and promoters, and ultimately control gene activity (13, 55 
14). In particular, lysine 4 of histone 3 monomethylation (H3K4me1) and trimethylation 56 
(H3K4me3) mark enhancers and promoters respectively (15). Acetylation of lysine 27 of histone 3 57 
(H3K27ac) is also associated with the active state of the element. 58 
In addition to histone modifications, DNA methylation (5-methylcytosine or 5mC) is 59 
associated with gene repression (16) and can disrupt the binding of many TFs (17, 18). DNA 60 
hydroxymethylation or 5-hydroxymethylcytosine (5hmC) is a recently discovered DNA 61 
modification that is produced by the oxidation of 5mC due to the activity of ten-eleven 62 
translocation proteins (TET1, TET2 and TET3). 5hmC plays an important role during 63 
mammalian development and cellular differentiation since Tet1/2/3 deficiency in ES cells (triple 64 
knockout cells) reduces their differentiation capabilities and also limits their developmental 65 
potential during embryogenesis (19). Although 5hmC was shown to be highly enriched at gene 66 
bodies in brain tissue, genome-wide enrichment studies in human and mouse embryonic stem 67 
cells (ESCs) confirms the presence of 5hmC at promoters and enhancers in addition to gene 68 
bodies (20).  69 
A mechanistic understanding of the interrelationship between TF binding, histone 70 
modification and DNA methylation states is only beginning to emerge. The establishment and 71 
maintenance of tissue-specific regions of histone and DNA modifications may be controlled by 72 
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TFs that can directly or indirectly interact with epigenetic modifiers (21), such as the histone 73 
acetylase CBP/p300 (22). Recent reports have identified TFs that interact with TET proteins to 74 
maintain low 5mC and high 5hmC at enhancers (23, 24). 75 
Studies transducing a combination of TFs into human fibroblasts to produce highly 76 
functional hepatocytes support HNF4A’s involvement in chromatin remodelling. These studies 77 
revealed that HNF4A is crucial for generating induced hepatocyte-like cells (iHeps) (25, 26) as 78 
HNF4A overexpression alone may be sufficient to generate these cells (27). These experiments 79 
suggest that HNF4A may help establish an appropriate epigenetic state to allow binding of 80 
additional TFs that regulate hepatocyte-specific gene expression. Here, we show that HNF4A 81 
maintains an active epigenetic state at cis-regulatory elements in hepatocytes and during liver 82 
differentiation. Loss of HNF4A during liver differentiation confirmed that HNF4A is required for 83 
establishment and maintenance of H3K27ac. Furthermore, HNF4A-mediated oxidation of 5mC 84 
during differentiation of hepatoblasts to hepatocytes is achieved by its interaction with TET3, a 85 
newly identified HNF4A target gene in hepatoblasts. Overall, we confirm that HNF4A-driven 86 
epigenetic changes are required for expression from its target genes during hepatocyte 87 
differentiation. These findings provide a novel mechanism through which HNF4A works as a 88 
master regulator to shape and maintain the epigenetic landscape in the liver. 89 
 90 
MATERIALS AND METHODS 91 
Mice and cell preparation 92 
Mouse protocols were approved by the University of British Columbia Animal Care committee. 93 
Livers were collected from 8 week old female C57BL6/J mice, perfused with 0.005% 94 
collagenase (STEMCELL Technologies) in PBS, minced with a razor blade and passed through 95 
a 40µm cell strainer. Hepatocytes were separated by low-speed centrifugation (50g x 30sec) (28). 96 
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Hepatoblast isolation from E14.5 livers was previously described (11). Alb-HNF4F/F;AlbERT2cre and 97 
Hnf4aF/F mouse were described in an earlier study (4). These mice were crossed with Tamoxifen 98 
inducible cre recombinase (specific to hepatocytes) expressing mouse. Mice used in this study 99 
were 6-8 weeks old and were treated with Tamoxifen (2mg/ml, intraperitoneal, subcutaneously) 100 
every other day (total 3 injections) for 7 days. Mice were killed by cervical dislocations under 101 
anesthesia and livers were collected 7th day post-injection. For HNF4F/F;AlbERT2cre mice, floxed cre 102 
negative mice without Tamoxifen were used as control. The HNF4a knockout animal studies 103 
and procedures were carried out in accordance with the Institute of Laboratory Animal 104 
Resources guidelines and approved by the National Cancer Institute Animal Care and Use 105 
Committee. All mice were housed in a pathogen-free animal facility under a standard 12-hour 106 
light/dark cycle and given pelleted NIH-31 chow diet (at NIH) or Envigo-Teklad 2920X (at BC 107 
Cancer) and water ad libitum. 108 
 109 
5mC and 5hmC Analysis 110 
Low input MeDIP-seq and hMeDIP-seq was previously described (29). DNA was sonicated to 111 
200-400bp using E-220 sonicator (Covaris) followed by end repair adapter ligation, and 112 
immunoprecipitation using anti-5mC or anti-5hmC antibodies. Two PCR reactions of 12 cycles 113 
using paired-end, indexed, Illumina PCR primers amplified the DNA for library preparation. Size 114 
selection of fragments <700bp was achieved on 8% polyacrylamide gels. Paired-end, 125 115 
nucleotide reads were generated on Illumina MiSeq or Illumina Hiseq 2500 platform (v3 116 
chemistry). Bioinformatic analysis of MeDIP and hMeDIP-seq data was performed as described 117 
in the supplementary material and methods section.  MeDIP and hMeDIP for locus-specific 118 
qPCR analysis were performed as described in Supplementary materials and methods.  119 
 120 
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Histone modification and transcription factor analysis 121 
ChIP was performed as previously described (30) with the following modifications. Cells or 122 
minced tissues were fixed with 1% formaldehyde (Sigma) for 10 minutes then quenched using 123 
125 mM glycine for 5 minutes at room temperature. MACs purified DLK1+ cells were fixed prior 124 
to cell sorting. Cells were lysed for 15 min on ice in lysis buffer (10mM Tris-HCl pH8, 10mM 125 
NaCl, 3mM MgCl2, 0.5% Nonidet P-40). Nuclei were pelleted and lysed for 30-60 min on ice 126 
with nuclear lysis buffer (50 mM Tris-HCl pH 8, 5 mM EDTA, 1% SDS). Samples were sonicated 127 
with Q Sonica Sonicator Q700 for 10 min total in 30 second cycles to generate fragments of 128 
200-500bp. Chromatin was diluted in ChIP dilution buffer (16.7 mM Tris-HCl pH 8, 167 mM 129 
NaCl, 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA) and Protein A/G beads (ThermoFisher) 130 
was added to clear the samples prior to addition of antibody.  Antibody (3µg for transcription 131 
factor and 2ug for histone modifications) was added to samples and incubated overnight at 4°C. 132 
Protein A/G beads (ThermoFisher) were added and samples were placed on a rotator at RT for 133 
4 hours. The samples were washed with low salt (20 mM Tris-HCl pH 8, 0.15 M NaCl, 2 mM 134 
EDTA, 0.1% SDS, 1% Triton X-100), high salt (20 mM Tris-HCl pH 8, 0.5 M NaCl, 2 mM EDTA, 135 
0.1% SDS, 1% Triton X-100), lithium chloride (10 mM Tris-HCl pH 8, 0.25 M LiCl, 1 mM EDTA, 136 
1% Nonidet P-40, 1% sodium deoxycholate) and TE buffer for 10 minutes each followed by 137 
elution with 0.1M sodium hydroxycholate in 1% SDS. DNA purification and qPCR analysis were 138 
the same as above.  For ChIP-seq library construction and Illumina Genome Analyzer 139 
sequencing was performed as described (15). Bioinformatic analysis of ChIP-seq data was 140 
performed as described in the Supplementary material and methods section.  141 
 142 
Cell culture and reagents 143 
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HepG2 and HEK293T cells were purchased from American Type Culture Collection (Manassas, 144 
VA). Cells were grown in DMEM media (STEMCELL Technologies) supplemented with 10% 145 
fetal bovine serum (HyClone Laboratories, Logan, UT). HPPL cells were generated and 146 
maintained as previously described (31). All cells were maintained in a humidified incubator at 147 
37°C and 5% CO2. For knockdowns, cells were seeded on 6 well plates and transfected with 148 
HNF4A and TET3 siRNA (Dharmacon) using RNAiMAX (ThermoFisher) for 72 hrs. siRNA used 149 
in this study are presented in Table S2. 150 
 151 
Co-immunoprecipitation (co-IP) 152 
HEK293T cells were transfected with an HNF4A expression vector (32) and HA-tagged TET3 153 
vector (Addgene #49446) alone and in combination using Polyethylenimine (PEI). Cells were 154 
lysed using lysis buffer (10mM Tris-HCl pH8, 10mM NaCl, 3mM MgCl2, 0.5% Nonidet P-40) and 155 
nuclei were collected on ice. CHAPS buffer was used for nuclear extraction and the lysate was 156 
incubated with 2ug of HNF4A antibody overnight at 4°C on a rocker. Protein A/G beads 157 
(ThermoFisher) were added (20ul) and samples were rotated for 30 minutes at RT. Beads were 158 
collected by centrifugation and extensively washed with lysis buffer. Proteins were eluted into 159 
SDS gel loading buffer by heating at 65°C. Proteins were separated using NuPAGE 4-12% gels 160 
(ThermoFisher), transferred to PVDF membranes, and analysed using the antibodies specified 161 
in Table S2. 162 
 163 
In situ proximity ligation assay (PLA) 164 
Embryonic (E14.5) and adult (8 weeks old) mouse livers were fixed with 4% paraformaldehyde 165 
(Sigma) at 4°C for 16-48 hrs, put through a sucrose gradient at 4°C, and embedded in OCT 166 
(TissueTek). Sections (4 µm) were permeabilized with Triton-X (0.1% v/v in PBS). PLA was 167 
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performed according to manufacturer’s instructions using the Duolink In situ PLA Kit (Sigma 168 
Aldrich). Fluorescent foci were imaged using the Zeiss Axio Imager M2. Cells were seeded on 169 
coverslips and washed twice with PBS before fixation and permeabilization. 170 
 171 
Statistical analysis 172 
Results are calculated as mean ±SEM derived from at least three independent experiments. 173 
Student’s t-test was used for qPCR data with GraphPad software. A p-value <0.05 was 174 
considered statistically significant. 175 
 176 
RESULTS 177 
Regions bound by HNF4A are associated with active histone and DNA modifications in 178 
hepatocytes 179 
HNF4A is a well-studied master regulator of hepatocyte identity; however, how it contributes to 180 
epigenetic plasticity in the liver is not very well understood. To address this, we investigated 181 
epigenetic modifications associated with HNF4A binding in adult mouse hepatocytes. We used 182 
our previously published HNF4A (11), H3K4me1 and H3K4me3 (15), and newly generated 183 
H3K27ac ChIP-seq datasets and examined the enrichment of histone modifications around 184 
HNF4A bound regions (HBRs) (Fig. 1A). HNF4A antibody used for ChIP-seq (Table. S2) 185 
identifies both embryonic and adult isoforms. Analysis of HNF4A ChIP-seq data revealed its 186 
preferential binding to intronic (47.35%), and distal intergenic regions (33.33%) with a small 187 
proportion at gene promoters (9.81%) (Fig. S1A). Examination of HBRs demonstrated a high 188 
enrichment of H3K4me1 and H3K27ac flanking these regions (Fig. 1A), suggestive of active 189 
enhancers. The active status of these enhancers was further confirmed by examination of 190 
mouse liver DNase-seq data (ENCODE), which shows very high signals, demonstrative of open 191 
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chromatin at HBRs (Fig. S1B). It is well established that active enhancers are associated with 192 
high 5hmC and low 5mC DNA modifications (14, 33). To examine the level of 5mC and 5hmC at 193 
HBRs, we isolated hepatocytes from mouse liver and performed MeDIP (Methylated DNA 194 
Immunoprecipitation) and hMeDIP (5-hydroxymethylated DNA Immunoprecipitation) followed by 195 
high-throughput sequencing. We observed that HBRs are enriched for 5hmC but depleted of 196 
5mC (Fig. 1A) as illustrated by the combined profile plot (Fig. 1B). The epigenetic status of 197 
HBRs, such as those near the genes Cdc42bpb, Rfx4 (Fig. 1C and D), Mgst3 and Ido2 (Fig. 198 
S1C & D), demonstrate the features of active enhancers. To validate our sequencing data, we 199 
confirmed 5mC depletion and 5hmC enrichment by MeDIP- and hMeDIP-qPCR at Cdc42bpb, 200 
Rfx4, Mgst3, Ido2, and Tet3 HBRs (Fig. 1E). Dazl, Tbx15 and IGd were included as positive, 201 
negative and no CpG controls, respectively. As expected, the level of 5mC at CpG islands 202 
associated with Dazl and Tbx15 was very similar to what we observed in our sequencing data 203 
(Fig. S1E and F). Overall, our data show that HBRs are enriched for H3K4me1 and H3K27ac, 204 
DNaseI hyper-sensitivity and 5hmC, which together indicate that HNF4A is primarily bound at 205 
active enhancers in hepatocytes. 206 
 207 
Regions bound by HNF4A do not require FOXA2 to have a transcriptionally permissive 208 
epigenetic state in hepatocytes 209 
We previously reported a significant overlap between HNF4A and FOXA2 bound regions 210 
(FBRs) in hepatocytes (11). As a pioneer factor, FOXA family members are capable of altering 211 
epigenetic modifications to regulate gene expression (24, 34). We, therefore, speculated that a 212 
high level of H3K4me1 and H3K27ac at HBRs could be due to FOXA2 occupancy at those 213 
sites. To address this, we performed K-means clustering (K=5) on HNF4A and FOXA2 bound 214 
regions in hepatocytes using ChAsE (35) and identified 5 clusters. As expected, a large overlap 215 
12 
 
12 
 
was observed between HBRs and FBRs (Cl2, Cl3 and Cl4), however, two clusters showed 216 
exclusive binding of either HNF4A or FOXA2 (Cl1 and Cl5, respectively) (Fig. 2A). Further, 217 
these clusters revealed distinctive histone and DNA signature patterns with Cl1 being enriched 218 
for H3K4me1, H3K27ac and 5hmC but depleted for 5mC compared to Cl5 (Fig. 2A). Given the 219 
importance of CpG density and its impact on 5mC, we performed CpG density analysis and 220 
found no significant difference between clusters, indicating 5mC enrichment in Cl5 is 221 
independent of CpG density (data not shown). To get a deeper insight into the difference in 222 
histone and DNA modifications associated with these clusters, we generated profile plots for 223 
H3K4me1 (Fig. 2B), H3K27ac (Fig. 2C), 5hmC (Fig. 2D), and 5mC (Fig. 2E). Profile plots 224 
identify the decreased level of H3K4me1, H3K27ac and 5hmC but an increase in 5mC in the 225 
cluster lacking HNF4A (Cl5). Furthermore, Cl5 regions show the least chromatin accessibility of 226 
all clusters based on DNaseI-seq data from mouse liver (Fig. S2A). Cluster 2, 3 and 4 displayed 227 
almost identical patterns of histone and DNA modifications. To explore whether there is a 228 
functional consequence of these differing chromatin states across clusters, we looked at gene 229 
expression for the single nearest gene transcriptional start site (TSS) within 20kb using RNA-230 
seq data from hepatocytes (11). Interestingly, genes associated with Cl5 have a significantly 231 
lower expression compared to all other clusters (Fig. 2F). The other four clusters, which all have 232 
bound HNF4A, had similar high expression levels characteristic of active transcriptional 233 
elements. Analysis of Cl1 confirmed no enrichment of motifs for FOXA in those regions 234 
suggesting no contribution of FOXA family members in maintaining a transcriptional permissive 235 
state at those regions (Fig. S2B). In contrast, motif analysis of cluster 5 revealed high 236 
enrichment for FOXA2 and low levels of enrichment for NFIC, HNF4A and CTCF (Fig. S2C). 237 
Interestingly, we observed low enrichment of HNF4A motifs in cluster 5 but our ChIP-seq data 238 
on HNF4A confirmed no binding at those locations. Pathway analysis to identify the functions of 239 
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genes associated with these clusters showed that the cluster 1 genes are primarily associated 240 
with metabolic functions (Fig. S2D) and cluster 5 genes are associated with various signalling 241 
pathways (Fig. S2E). Overall these findings, confirms that regions bound by HNF4A, 242 
irrespective of presence or absence of FOXA2, are accessible and actively enhancing 243 
transcription of genes primarily associated with metabolic functions in liver.  244 
 245 
Without HNF4A, H3K27ac and 5hmC are significantly decreased at HBRs in hepatocytes 246 
With the observation that H3K27ac and 5hmC are enriched at HNF4A bound regions, we 247 
hypothesized that HNF4A is required for appropriate enhancer modifications that ensure precise 248 
expression requirements independent of FOXA2. To test this, we took advantage of a 249 
Tamoxifen-inducible, hepatocyte-specific, HNF4A knockout (KO) mouse (4) and performed ChIP-250 
, MeDIP- and hMeDIP-qPCRs on WT and KO livers. For our analysis, we investigated sites 251 
bound by both HNF4A and FOXA2 (Cl2, Cl3 and Cl4, see Fig. 3A for example) as well as sites 252 
bound by HNF4A alone (Cl1, see Fig. 3B for example) for changes in H3K27ac patterns.  253 
H3K27ac ChIP-qPCR in WT and KO livers showed that loss of HNF4A resulted in decreased 254 
H3K27ac at all sites, indicating a requirement for HNF4A in ensuring H3K27ac is maintained.  255 
Positive and negative controls that are not normally bound by HNF4A in the liver (Gapdh and 256 
Six1) had no significant changes in H3K27ac levels (Fig. 3C). Furthermore, in KO livers, the 257 
same genomic locations exhibited a reduction in 5hmC to same extent (almost two fold change) 258 
for both HNF4A only and HNF4A/FOXA2 shared regions (Fig. 3D). We also observed a small 259 
increase in 5mC levels in HNFKO livers at most loci examined (Fig. S3A). This investigation 260 
was extended in vitro using siRNA-mediated knockdown in HepG2 cells. We confirmed a 261 
reduction of HNF4A mRNA and protein expression (Fig. S3B) and validated that HNF4A bound 262 
to regions in HepG2 cells as identified in ENCODE data (e.g., RBKS, MGST2, SLCO4C1, 263 
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APOA4, PRLR and AGXT) (Fig. S3C). After siRNA depletion of HNF4A, these sites had 264 
significantly decreased levels of 5hmC (Fig. S3D) and increased levels of 5mC (Fig. S3E). 265 
Together, these findings suggest that HNF4A is required to maintain high levels of H3K27ac 266 
and 5hmC in cell lines and in vivo. 267 
 268 
The gain of HNF4A during differentiation results in increased H3K27ac and 5hmC at HBR 269 
associated enhancers 270 
We have previously reported the phenomenon of enhancer switching during liver differentiation 271 
where TFs, including HNF4A, show distinct binding sites in embryonic hepatoblasts and adult 272 
hepatocytes (11). To determine if H3K27ac is altered in response to differential binding of HNF4A 273 
in hepatoblasts and hepatocytes, we compared ChIP-seq data for HNF4A and H3K27ac in 274 
hepatoblasts purified from E14.5 embryonic livers and in adult hepatocytes. We identified 2765 275 
hepatocyte-enriched HBRs that are present in differentiated hepatocytes but not bound in 276 
hepatoblasts (examples are shown in Fig. 4A left and right). Of note, these hepatocyte-enriched 277 
HNF4A binding sites showed a gain of H3K27ac (Fig. 4B) in hepatocytes compared to 278 
hepatoblasts. In contrast, sites at which HNF4A-binding is lost after differentiation (hepatoblast-279 
enriched) showed decreased H3K27ac in adult hepatocytes (Fig. S4A). Moreover, hepatocyte-280 
enriched HBRs show decreased levels of 5mC (Fig. 4C) and increased levels of 5hmC (Fig. 4D) 281 
in hepatocytes compared to hepatoblasts, suggesting that the gain of HNF4A in those regions 282 
results in the oxidation of 5mC to 5hmC. Notably, genes associated with HNF4A sites gained in 283 
hepatocytes were significantly more highly expressed in hepatocytes compared to hepatoblasts 284 
(individual and global examples are shown in Fig. 4E and 4F), whereas genes associated with 285 
regions no longer bound by HNF4A in the hepatocytes showed the opposite trend (Fig. S4B). 286 
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Overall these findings support an important role of HNF4A in cell type-specific gene regulation 287 
by ensuring high levels of H3K27ac and 5hmC at gene regulatory regions.  288 
 289 
HNF4A and TET3 proteins physically interact 290 
We speculated that HNF4A interacts with TET proteins to maintain low-levels of 5mC at bound 291 
regions through oxidation to 5hmC. We focused on TET3 due to its high expression in 292 
hepatocytes (Fig. 5A and 5B) and its known interactions with another nuclear receptor family 293 
member, TRα1 (36). Of note, TET3 co-immunoprecipitation with HNF4A in HepG2 cells, which 294 
express high levels of both HNF4A and TET3, confirmed that the two proteins interact (Fig. 5C). 295 
This interaction was also confirmed using the expression of tagged versions of the proteins in 296 
HEK293T cells (Fig.SB). Importantly, the TET3-HNF4A interaction was observed in nuclear 297 
lysates isolated from mouse hepatocytes (Fig. 5D) as well as hepatoblasts (Fig. 5E). Proximity 298 
ligation assay (PLA) on adult and embryonic mouse liver cryosections validated the close 299 
association between HNF4A and TET3 (Fig. 5F) in nuclei of hepatoblasts and hepatocytes in 300 
vivo. These PLA findings were further validated in HEK293T cells using the expression of Myc-301 
HNF4A and Flag-TET3 (Fig. S5D). Together, our findings suggest that HNF4A physically 302 
interacts with TET3, in vivo, to mediate the active 5hmC status at regulatory regions to facilitate 303 
gene transcription. These findings suggest that the presence of both TET3 with HNF4A is 304 
required for expression of genes associated with HBRs. 305 
 306 
TET3 is a direct transcriptional target of HNF4A 307 
In hepatoblasts, we observed a strong intragenic HNF4A binding site approximately 19kb 308 
downstream from the Tet3 transcriptional start site. This HNF4A site co-localizes with active 309 
histone modifications (H3K4me1 and H3K27ac), suggesting an active enhancer (Fig. 6A). 310 
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Knockdown of HNF4A in mouse HPPL cells (hepatic progenitor cells proliferating on laminin), 311 
which are capable of generating hepatocyte and cholangiocytes similar to mouse hepatoblasts, 312 
caused a reduction of Tet3 mRNA expression (p<0.0001) and protein levels (Fig. 6B), 313 
suggesting that HNF4A regulates Tet3 expression in hepatic cells.  To determine if the HNF4A 314 
bound enhancer in Tet3 (mTET3E, a 405bp region) is functional; we used luciferase reporter 315 
assays in HEK293T cells.  HNF4A overexpression significantly increased (p>0.0001) enhancer 316 
activity of mTET3E (Fig. 6C). We confirmed the luciferase results using HepG2 cells that 317 
endogenously express HNF4A (Fig. 6D). Furthermore, ENCODE ChIP-seq data in HepG2 cells 318 
demonstrated a similar HNF4A bound region with active histone modifications between exon 2 319 
and 3 of TET3 in the human genome (Fig. S6B). Luciferase assays with the human region 320 
(332bp) in HEK293T cells with HNF4A overexpression (Fig. S6C), and in HepG2 cells with 321 
endogenous HNF4A (Fig. S6D) confirmed HNF4A-mediated regulation of TET3. 322 
The mouse TET3 enhancer contains two HNF4A motifs (HNF4A-1 and HNF4A-2) (Fig. 323 
6E). To test which of the HNF4A motif conveyed the enhancer activity, the motifs were deleted 324 
sequentially in the reporter construct containing the mouse enhancer and the activity was 325 
measured in both HepG2 (Fig. 6F) and HEK293T cells (Fig. S6A). As expected, combinatorial 326 
deletion of these motifs diminished luciferase activity in HepG2 cells (Fig. 6F). Of note, in 327 
HEK293T cells, the deletion of the two motifs did not have any additional effect compared to the 328 
single deletions, suggesting that the hepatic environment of the HepG2 cells may contain 329 
additional factors required for this regulation that are absent in the HEK293T cells. Overall, our 330 
results suggest that HNF4A directly regulates Tet3 in the hepatic cells and TET3 then, in turn, 331 
interacts with HNF4A to control the epigenetic environment of regions by ensuring 5hmC and 332 
H3K27ac are maintained. 333 
 334 
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DISCUSSION 335 
HNF4A is a key TF in the liver as its loss is associated with transcriptional repression of genes 336 
(5, 10). Although various TFs were shown to regulate gene expression by influencing histone (24, 37) 337 
and DNA modifications at gene regulatory regions (24, 37, 38), the role of HNF4A in epigenetic-338 
mediated gene regulation in liver is not well defined.  339 
  Here, we show that HNF4A, a master regulator of hepatocyte differentiation, controls 340 
gene expression through its influence on epigenetic modifications in hepatoblasts and 341 
hepatocytes. In particular, we show that HNF4A binding in hepatocytes is almost exclusively 342 
associated with active histone modifications (H3K4me1 and H3K27ac) and DNA 343 
hydroxymethylation (5hmC) at enhancers, supporting a primary role of HNF4A in transcriptional 344 
activation in the liver. Moreover, our data suggest that HNF4A is required for the presence of 345 
H3K27ac and 5hmC since the loss of HNF4A in adult liver, through an inducible knockout 346 
model, reduces these active enhancer signatures at HNF4A bound regions. In addition, regions 347 
bound by HNF4A in hepatoblasts but not hepatocytes have reduced levels of H3K27ac and 348 
5hmC in hepatocytes. This loss correlates with reduced transcription from the associated genes 349 
(Fig. 7). Finally, HNF4A bound regions acquired across differentiation in hepatocytes are 350 
enriched for H3K27ac and 5hmC in hepatocytes. Together this data establishes HNF4A as a 351 
facilitator of the active enhancer state.  352 
Previous studies have suggested that HNF4A plays multiple roles in chromatin 353 
reorganization: ectopic HNF4A expression in fibroblasts was shown to induce DNase1 354 
hypersensitivity of the Serpin gene cluster at 14q32.1 to transcriptionally regulate α1-antitrypsin 355 
and corticosteroid binding globulin (39). This supports a role of HNF4A in the establishment of 356 
active enhancers(39). In addition, HNF4A may regulate chromatin indirectly by controlling the 357 
18 
 
18 
 
expression of chromatin remodelling genes, such as Smarcd3 and Cdt1, as their expression is 358 
altered in HNF4A KO livers (40). 359 
The mechanisms through which HNF4A alters the epigenome are likely to be complex. 360 
HNF4A was shown to directly interact with CBP/p300, which may account for its ability to 361 
regulate H3K27ac (2, 41, 42). Our data suggest that in the absence of HNF4A, histone acetylases 362 
either are not recruited or not able to function at HNF4A enhancers, despite the potential 363 
presence of other TF binding. For example, HNF4A frequently co-binds to regions with FOXA2; 364 
however, at regions that are bound by FOXA2 alone very little H3K27ac is evident. In addition, 365 
in HNF4A KO livers, H3K27ac was reduced at regions bound by either HNF4A only or 366 
FOXA2/HNF4A, indicating HNF4A is primarily responsible for maintaining active epigenetic 367 
signatures at these locations. In addition to FOXA family members, HNF4A was previously 368 
shown to recruit several coactivators such as glucocorticoid receptor interacting protein 1, 369 
steroid receptor coactivator1 and cAMP response element binding proteins to regulate gene 370 
expression (41, 43). The role of these co-factors is not clear. Moreover, we observed that RXRA, 371 
ESRB and HINFP motifs were enriched in the HNF4A bound regions which lack FOXA2. Thus, 372 
H3K27ac at HNF4A binding sites could be affected by interactions with other TFs.   373 
In addition to H3K27ac, we observed depletion of 5mC and enrichment of 5hmC around 374 
HNF4 bound regions. In HNF4A KO livers, 5hmC was reduced at HBRs. A recent study 375 
investigating the role of HNF4A depletion on DNA modifications showed that HNF4A loss can 376 
impact global 5mC and 5hmC to a small extent (44). By first identifying HNF4A-bound regions, 377 
we were able to observe significant changes in 5hmC upon HNF4A depletion both in vivo and in 378 
vitro, demonstrating its role in the maintenance of this active mark at enhancers (Fig. 7). 379 
Interestingly, we observed only a small increase in 5mC at HBRs in HNF4A KO livers, 380 
suggesting that either recovery of 5mC is slower than 5hmC loss or it does not occur.  A 381 
19 
 
19 
 
previous study observed a similar effect at FOXA1 bound enhancers in LNCaP prostate cancer 382 
cells in which knockdown of FOXA1 reduced 5hmC without gain of 5mC (24). Furthermore, it has 383 
previously been shown that 5hmC abundance represents only ~10% of the 5mC level in 384 
embryonic stem cells,(45), thus changes in 5mC upon HNF4A depletion in the whole liver may be 385 
difficult to observe. However, we did observe a clear gain in 5mC in HepG2 cells upon HNF4A 386 
knockdown (Fig. S3E).  387 
In the present study, we show that HNF4A functions to regulate DNA methylation in the 388 
surrounding genomic regions through interactions with TET3. Of interest, the HNF4A binding 389 
motif does not contain a CG which can be methylated, thus making it a methylation-insensitive 390 
TF (11, 17). Thus, HNF4A may bind to its motif and then recruit TET proteins to oxidize the 5mC to 391 
5hmC in the surrounding regions. TET2 and TET3 are known to be required for this 5mC 392 
oxidation process in hepatocytes (46). Here, we focused on TET3 because it is more highly 393 
expressed compared to other TETs in the liver and is known to interact with a TF,  the nuclear 394 
receptor protein TRα1(36). Since TET2 is also expressed in liver, HNF4A may also interact with 395 
TET2 in vivo. It should be mentioned that while we focused on 5hmC at HBRs, other DNA 396 
modifications, such as 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) may also be 397 
present and important. A recent study showed that TET3 can identify and facilitate removal of 398 
5caC by base excision repair to achieve demethylation of gene regulatory regions (47). Thus, 399 
future work is needed to examine the entire 5mC oxidation pathway in the liver.  400 
In summary, we show that HBRs are associated with a high level of H3K27ac and 401 
5hmC, likely due to HNF4A interactions with CBP/p300 and TET3 respectively (Fig. 7). We 402 
identified clusters (Fig. 2A and 7) where loss of HNF4A affects H3K27ac and 5hmC levels to 403 
different extents (Fig. 3 and 7). We also confirmed that the loss of HNF4A in a human hepatoma 404 
cell line, HepG2, produced similar changes in DNA modifications as observed in Hnf4a KO 405 
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mouse livers, indicating similar mechanisms of gene regulation (Fig. S3 and Fig. 7).Thus, we 406 
have identified a mechanism through which HNF4A regulates epigenetic plasticity in 407 
hepatocytes. We have also confirmed HNF4A function in establishment and maintenance of 408 
H3K27ac and 5hmC at enhancers and that this function can be independent of FOXA2. 409 
Whether the two epigenetic alterations established and maintained by HNF4A occur 410 
concomitantly or are unrelated remains to be determined. 411 
 412 
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 542 
FIGURE LEGENDS 1 
Fig.1 Active enhancer signatures are associated with HNF4A bound regions (HBRs). (A) 2 
Heatmap displaying the histone (H3K4me1, H3K4me3, and H3K27ac) and DNA modifications 3 
(5mC and 5hmC) patterns at HBRs in mouse hepatocytes. A 5kb window is shown with the 4 
summit of HNF4A binding in the centre of each panel. The coloured bar with blue, yellow and 5 
red colour represents low, moderate and high enrichment respectively (B) Aggregation plots of 6 
MeDIP (red) and hMeDIP (blue) signals at HBRs (black line). (C and D) UCSC genome browser 7 
view of Cdc42bpb and Rfx4 loci showing enrichment of HNF4A (black), H3K27ac (orange), 8 
H3K4me1 (dark green), H3K4me3 (light green), 5mC (red), 5hmC (blue) and DNase-seq signals 9 
(pink) at HBR (highlighted). (E) Bar graph showing 5mC (Red bars) and 5hmC (blue) levels at 10 
HBR associated genes Cdc42bpb, Ido2, Mgst3, Rfx4 and Tet3 (black line). Dazl, Tbx15 and IGd 11 
genomic regions were used as 5mC positive, negative and non-CpG controls, respectively. 12 
(n=3). Values represent mean ±SEM. 13 
 14 
Fig. 2 HNF4A bound regions show high H3K27ac and 5hmC in the absence of FOXA2. (A) 15 
Heatmap of K-means clustering (K=5) of TF (HNF4A and FOXA2) bound regions and 16 
H3K4me1, H3K4me3, H3K27ac, 5hmC and 5mC. Clusters Cl1 and Cl5 represent HNF4A only 17 
and FOXA2 only regions, respectively. Cl2/3/4 represents HNF4A/FOXA2 shared regions. A 18 
5kb window is shown with transcription factor binding in the middle of each panel (B) 19 
Enrichment plots of H3K4me1 (C) H3K27ac (D) 5hmC (E) 5mC for Cl1, Cl2, Cl3, Cl4 and Cl5 20 
represented by red, yellow, cyan, blue and black lines, respectively (F) Scatter dot plot 21 
representing RNA-seq Log2 RPKM values of all genes associated with clusters. A significant 22 
difference was tested using Kruskal-Wallis one-way ANOVA with Dunn's post-test correction; 23 
****p < 0.001.  24 
 25 
Fig. 3 HNF4A is required for maintenance of H3K27ac and 5hmC at enhancers. (A) 26 
Genomic map displaying ChIP (TF and histone modifications), MeDIP, hMeDIP and DNase-seq 27 
signals at HNF4A and FOXA2 shared sites at Ido2 locus (highlighted region) (B) Example of 28 
HNF4A only bound region at Acss3 locus and enrichment of histone and DNA modifications at 29 
HBR (highlighted region) (C) ChIP-qPCR displaying H3K27ac enrichment in WT and HNF4A 30 
conditional knockout (HNF4A F/F; AlbERT2cre) livers at HNF4A/FOXA2 shared (Apoa5, Nnmt, 31 
Agxt, Prlr and Rfx4) and HNF4A only regions (Hnmt, Ccnd1, Acss3 and G6pc). Gapdh and Sixl1 32 
represent H3K27ac positive and negative control for WT liver samples (D) Bar plot showing the 33 
5hmC level at HNF4A/FOXA2 shared (Apoa5, Nnmt, Agxt, Prlr and Rfx4) and HNF4A only 34 
genes (Hnmt, Ccnd1, Acss3 and G6pc)  35 
 36 
Fig. 4 Gain of HNF4A binding during hepatoblast to hepatocyte differentiation 37 
accompanies histone and DNA modifications.  (A) Genome maps for HNF4A target genes 38 
Apoa5 and Nnmt, with normalised ChIP-seq signals for H3K4me1 (dark green), H3K27ac 39 
(orange) and HNF4A (black) from hepatoblast and hepatocyte showing a gain of HNF4A and 40 
increased level of H3K27ac at hepatocyte-specific HBR (highlighted). DNase-seq data from the 41 
liver is shown in pink. (B) Heatmap showing HNF4A sites gained during hepatoblast to 42 
hepatocyte differentiation are accompanied by H3K27ac. Colour bar below heat map represents 43 
the enrichment level. (C) 5mC level at HNF4A gained loci in hepatoblasts and hepatocytes. (D) 44 
5hmC level at HNF4A gained sites in hepatoblasts and hepatocytes. (n=3). Values represent 45 
mean ±SEM *P<0.05, **P<0.01 by t-test. (E) RNA-seq with log2RPKM values of HNF4A target 46 
genes (Apoa5, Nnmt, Agxt, Prlr, Ido2 and Rfx4) in hepatoblasts and hepatocytes. (F) Box plot 47 
showing RNA-seq values (Log2RPKM) in hepatoblast and hepatocyte for genes that gained 48 
HNF4A binding during differentiation. 49 
Fig. 5 HNF4A interacts with TET3 in vivo and in vitro. (A) RNA-Seq RPKM values of Tet1, 50 
Tet2 andTet3 in hepatocytes. (B) Western blot showing expression of TET3 in hepatoblast and 51 
hepatocytes with β-Actin control. (C) Immunoprecipitation and western analysis of HepG2 lysate 52 
which was subjected to immunoprecipitation using anti-HNF4A and negative control (IgG) 53 
antibody followed by western for HNF4A and TET3. (D) Hepatocytes isolated from 3 different 54 
female livers were subjected to immunoprecipitation using anti-HNF4A and negative control 55 
(IgG) antibody followed by western using HNF4A and TET3 antibody. (E) Immunoprecipitation 56 
and western analysis of hepatoblast lysates subjected to IP using anti-HNF4A and IgG antibody. 57 
(F) Cartoon describing the proximity ligation assay (PLA) technique (top). PLA on adult (middle) 58 
and embryonic liver (bottom) sections using an antibody against HNF4A and TET3 confirm 59 
endogenous interaction shown as yellow dots inside DAPI stained nuclei (Blue). 60 
 61 
Fig. 6 Tet3 transcription is directly regulated by HNF4A. (A) Genomic maps showing 62 
HNF4A, H3K4me1 and H3K27ac enrichment at Tet3 locus in hepatoblast (highlighted) (B) 63 
Hnf4a and Tet3 mRNA and protein level in siControl and siHnf4a knockdown in HPPL cells (96 64 
hrs).  (C) Luciferase assays using control (PGL3-EIBP-Empty and PDGT-Empty), HNF4A 65 
overexpression (PDGT-HNF4A) and the mouse Tet3 enhancer (PGL3EIBP-mTet3E) constructs. 66 
Constructs were overexpressed in HEK293T cells in combinations shown below the graph (+ 67 
transfected and – not transfected) (D) Luciferase assays in HepG2 cells transfected with control 68 
(PGL3-EIBP-empty) or Tet3 enhancer luciferase constructs (PGL3EIBP-mTET3E). (E) 69 
Schematic representation of the Tet3 enhancer region (mTet3E) cloned for luciferase assays. 70 
Sequence alignments show two HNF4A motifs (HNFA-1 and HNF4A-2) within the Tet3 71 
enhancer. The table represents the constructs generated by deleting HNF4A motifs. (F) 72 
Luciferase assays in HepG2 cells transfected with mTET3E or mTET3E carrying one deleted 73 
HNF4A motif (mTET3EΔ1 or mTET3EΔ2) or mTET3E with both HNF4A motifs deleted 74 
(mTET3Δ1Δ2). Values represent the mean ± SEM. p*<0.05, **p<0.01, ****p<0.0001 from t-test. 75 
 76 
Fig. 7 Role of HNF4A in establishing and maintaining epigenetic modifications at 77 
enhancers. HNF4A is required for the maintenance of H3K27ac and 5hmC in mouse (top) and 78 
human (bottom). Coloured bars represent the TF (HNF4A- black) occupancy and level of 79 
H3K27ac (orange), 5mC (red) and 5hmC (blue) in WT and HNF4A KO liver. Loss of H3K27ac 80 
and 5hmC at gene regulatory regions result in decreased expression (sky-blue) from HNF4A 81 
target genes. Cluster 1 (left panel) represents HNF4A only regions where HNF4A interacts with 82 
CBP/p300 and TET3 to maintain H3K27ac and 5hmC levels at HBRs. Loss of HNF4A in mouse 83 
liver (HNF4A KO liver) shows reduction in H3K27ac and 5hmC and gain of 5mC at cluster 1 84 
regions, represented by coloured bars. Cluster 2, 3 and 4 (middle panel) represents HNF4A and 85 
FOXA2 shared regions where 5hmC and H3K27ac level was maintained by HNF4A’s interaction 86 
with epigenetic modifiers such as TET3 and CBP/p300. Similar to the cluster 1, the loss of 87 
HNF4A results in reduction of H3K27ac, 5hmC and gain of 5mC which directly affects 88 
transcription from associated genes. Cluster 5 (right panel) represents regions only occupied by 89 
FOXA2 in hepatocytes, with very low H3K27ac and 5hmC but having higher 5mC (right panel). 90 
The genes associated with these regions show lower expression (sky blue bars) as compared to 91 
the other clusters. In human liver carcinoma cells (HepG2 cells), HNF4A KD also produced 92 
similar changes in the level of 5hmC and 5mC (shown below the three mouse panels).  93 
 94 
SUPPLEMENTARY FIGURE LEGENDS 95 
Fig. S1 Epigenetic signatures associated with HNF4A binding in hepatocytes.  (A) 96 
Genomic distribution of HNF4A bound regions in hepatocytes (B) DNase-seq signals at all 97 
HBRs in mouse liver (C and D) UCSC genome browser view showing enrichment of HNF4A, 98 
H3K27ac H3K4me1, H3K4me3, 5mC, 5hmC and DNase-seq signals at HBR (highlighted). (E 99 
and F) UCSC maps of Dazl and Tbx15 displaying the level of 5mC at respective CpG Islands.  100 
 101 
Fig. S2 HNF4A does not require a FOXA family member for its influence on epigenetic 102 
modifications at HBRs. (A) DNase-seq signals for each cluster in hepatocytes (B) Motif 103 
analysis of Cluster 1 regions showing enrichment for potential transcription factor binding sites. 104 
(C)  Motif analysis of Cluster 5 regions showing enrichment for potential transcription factor 105 
binding sites. (D) Pathway analysis of cluster 1 associated genes in liver. (E) Pathway analysis 106 
of cluster 5 genes in liver. 107 
 108 
Fig. S3 HNF4A maintains a high level of 5hmC at its binding sites in vitro (A) The 5mC 109 
level at shared and HNF4A only gene loci in WT and HNF4A KO livers. n=3.Values represent 110 
mean ±SEM. (B) Left: qRT-PCR analysis of HNF4A in HepG2 cells 72 hours following HNF4A 111 
knockdown (siHNF4a) to control (siCntrl) data is normalised to GAPDH. (n=3). Values represent 112 
the mean ± SEM. **p<0.01 from t-test. Right: WB analysis of HNF4A in HepG2 cells 72 hours 113 
following HNF4A knockdown (siHNF4a). (C) ChIP-qPCR analysis displaying enrichment of 114 
HNF4A at RBKS, MGST2, SLCO4C1, APOA4, PRLR and AGXT loci. (n=3) Values represent 115 
the mean ± SEM. DAZL promoter and region on Chr17 serve as negative control. (D) hMeDIP-116 
qPCR of HNF4A occupied regions at RBKS, MGST2, SLCO4C1, PRLR and AGXT in siCntrl 117 
and siHNF4A HepG2 samples. (E) MeDIP qPCR of HNF4A target genes in HepG2, DAZL 118 
serves as a 5mC positive control.  119 
 120 
Fig. S4 Hepatoblast-enriched HNF4A binding shows decreased H3K27ac and reduced 121 
transcription from associated genes in hepatocytes (A) heat map displaying HNF4A and 122 
H3K27ac ChIP signals in hepatoblasts and hepatocytes. Colour bar below indicates the strength 123 
of signals. (B) Box plot showing RNA-seq values (Log2RPKM) in hepatoblasts and hepatocytes 124 
for genes that lost HNF4A binding during differentiation. Significance was tested using a t-test, 125 
****p<0.0001. 126 
 127 
Fig. S5 HNF4A and TET3 interact to regulate HNF4A target genes in hepatic cells. (A) 128 
Western showing protein expression of TET2 in hepatoblasts and hepatocytes (top) and β-Actin 129 
as loading control (bottom). (B) Co-immunoprecipitation in which Myc-HNF4A and flag-TET3 130 
were ectopically expressed in 293T cells. IP was performed using anti-Myc and a negative 131 
control antibody (IgG), followed by western analysis with Flag (top) and Myc (bottom) antibody. 132 
(C) mRNA levels of TETs in HepG2 cells. (D) Proximity Ligation Assay for ectopically expressed 133 
Myc-HNF4A and Flag-TET3 confirming the interaction in HEK293T cells (shown by Red dots). 134 
(E) Secondary only probes for PLA analysis for embryonic (left) and adult liver (right) sections. 135 
Nuclei are stained with DAPI (blue). 136 
 137 
Fig. S6 HNF4A regulates TET3 expression (A) Luciferase assays were performed in 138 
HEK293T cells. Cells were transfected with mouse Tet3 enhancer construct (PGL3EIBP-139 
mTET3E) or enhancer carrying one deleted HNF4A motif (mTET3EΔ1 or mTET3EΔ2) and both 140 
deleted HNF4A motifs (mTET3Δ1Δ2) with overexpression of HNF4A (PDGT-HNF4A). (B) 141 
UCSC maps using ENCODE ChIP-seq data displaying HNF4A, H3K4me1 and H3K27ac 142 
enrichment at TET3 locus in HepG2 cells. The highlighted region was cloned in luciferase 143 
vector. (C) Luciferase assay using control (PGL3-EIBPEmpty and PDGT-empty), HNF4A 144 
overexpression (PDGT-HNF4A) and cloned human TET3 (PGL3EIBP-hTET3) enhancer 145 
constructs. Constructs were overexpressed in HEK293T cells in combinations shown below the 146 
graph (+ transfected and – not transfected). (D) Luciferase assays in HepG2 cells transfected 147 
with control (PGL3-EIBP-empty) or human TET3 (PGL3EIBP-hTET3E) enhancer luciferase 148 
constructs. 149 













